Paper2187809
Containment as a mechanism of nonspecific enhancement of defenses against bacterial infection.
Polk HC and 2 others. Infect Immun, 1990. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Containment as a mechanism of nonspecific enhancement of defenses against bacterial infection. Papers, record 2187809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2187809
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Containment as a mechanism of nonspecific enhancement of defenses against bacterial infection.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetylmuramyl-Alanyl-Isoglutamine | Major topic |
| Klebsiella Infections | Major topic |
| Animals | |
| Immunotherapy | |
| Klebsiella pneumoniae | |
| Mice | |
| Sepsis |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 362430 | Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents. | Prog Allergy | 1978 | https://conductscience.org/library/papers/362430 | PubMed |
| 2 | 6362769 | Muramyl dipeptide increases tolerance to shock and bacterial challenge in mice. | Br J Surg | 1984 | https://conductscience.org/library/papers/6362769 | PubMed |
| 3 | 457275 | Stimulation of the reticuloendothelial system of mice by muramyl dipeptide. | Infect Immun | 1979 | https://conductscience.org/library/papers/457275 | PubMed |
| 4 | 6985758 | Corynebacterium parvum: immunomodulation in local bacterial infections. | Surgery | 1980 | https://conductscience.org/library/papers/6985758 | PubMed |
| 5 | 5327558 | Birth-death and other models for microbial infection. | Nature | 1965 | https://conductscience.org/library/papers/5327558 | PubMed |
| 7 | 7125729 | Nonspecific enhancement of resistance to bacterial infection: evidence of an effect supplemental to antibiotics. | Ann Surg | 1982 | https://conductscience.org/library/papers/7125729 | PubMed |
| 8 | 321136 | Target cells for the activity of a synthetic adjuvant: muramyl dipeptide. | Cell Immunol | 1977 | https://conductscience.org/library/papers/321136 | PubMed |
| 9 | 6256464 | Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide. | J Exp Med | 1980 | https://conductscience.org/library/papers/6256464 | PubMed |
| 10 | 359336 | The macrophage, target cell of the synthetic adjuvant muramyl dipeptide. | Eur J Immunol | 1978 | https://conductscience.org/library/papers/359336 | PubMed |
| 11 | 325566 | Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/325566 | PubMed |
| 12 | 6743532 | Enhancement of the local inflammatory response to bacterial infection by muramyl dipeptide. | Br J Exp Pathol | 1984 | https://conductscience.org/library/papers/6743532 | PubMed |
| 14 | 14438353 | Host mechanisms which act to remove bacteria from the blood stream. | Bacteriol Rev | 1960 | https://conductscience.org/library/papers/14438353 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8141571 | Treatment of Klebsiella pneumoniae septicemia in normal and leukopenic mice by liposome-encapsulated muramyl tripeptide phosphatidylethanolamide. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/8141571 | PubMed |
| 1729201 | Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide in treatment of experimental Klebsiella pneumoniae infection. | Infect Immun | 1992 | https://conductscience.org/library/papers/1729201 | PubMed |
| 1505872 | Bacterial infection modulated by glucan: a search for the host defense potentiation mechanisms. | Folia Microbiol (Praha) | 1992 | https://conductscience.org/library/papers/1505872 | PubMed |
| 1399000 | Roles of peripheral leukocytes and tissue macrophages in antibacterial resistance induced by free or liposome-encapsulated muramyl tripeptide phosphatidylethanolamide. | Infect Immun | 1992 | https://conductscience.org/library/papers/1399000 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2187809
GET https://conductscience.org/api/papers/v1/2187809/authors